HF
RPID icon

HRT Financial’s Rapid Micro Biosystems RPID Stock Holding History

HRT Financial’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-26,010
Closed -$276K – 3754
2021
Q4 		$276K Buy
+26,010
New +$406K ﹤0.01% 2325

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

HRT Financial's RPID Position: Q1 2022 in Review

HRT Financial sold out of Rapid Micro Biosystems (RPID) in Q1 2022, closing a stake of 26,010 shares — an estimated $276K sold.

HRT Financial first reported a position in RPID in Q4 2021 and held it in 1 quarter. The position peaked at $276K in Q4 2021. 59 funds tracked by Wall St. Rank hold RPID as of Q1 2022.

  • HRT Financial reported no remaining Rapid Micro Biosystems position as of Q1 2022 after selling out during the quarter.
  • HRT Financial sold 26,010 Rapid Micro Biosystems shares in Q1 2022, an estimated $276K.
  • HRT Financial first reported a position in Rapid Micro Biosystems in Q4 2021 and held it in 1 quarter.
  • HRT Financial's Rapid Micro Biosystems position peaked at $276K in Q4 2021.
  • 59 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.